2-METHYL-3-HYDROXYBUTYRYL-CoA DEHYDROGENASE DEFICIENCY (HSD10) | |
17-BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY; HSD10 MITOCHONDRIAL DISEASE; HSD10MD | |
300438
OMIM = Online Mendelian Inheritance of Men | |
391417 | |
3-hydroxyacyl-CoA dehydrogenase type-2 | |
1.1.1.178, 1.1.1.35 | |
Xp11.22 |
|
E72.8 | |
very rare (<1:1000000) X-linked dominant mutation in the HSD17B10 gene most patients are male, less severe phenotype in females Clinical symptoms as well as the impressive lactic acidosis found in some patients may mimic a mitochondrial disease [Perez-Cerda C et al. 2005] | |
Laboratory findings | Tiglylglycine inc (urine) 2-Ethylhydracrylic acid inc (urine) 2-Methyl-3-hydroxybutyric acid inc (urine) Ketone bodies (urine) normal/inc (urine) L-Lactic acid inc (cerebrospinal fluid) L-Lactic acid inc (urine) L-Lactic acid inc (serum) |
Symptoms | anemia basal ganglia, changes, lesions, calcifications (MRI, CT) behavior, hyperactive, restless cardiomyopathy cerebral atrophy chorea or athetosis dysarthria early death hearing defect, deafness hypotonia ketosis, ketoacidosis lactic acidosis mental retardation metabolic acidosis motor retardation MRI, brain, white matter abnormalities [-] nystagmus onset, childhood onset, infancy onset, neonatal optic atrophy periventricular white matter changes progressive neurologic defect retinopathy seizures sex: male > female speech development, delayed, abnormal tremor or twitching white matter changes, abnormalities |